APOE(apolipoprotein E) 转至新版数据库
基因简称(symbol)
基因种类(locus group)
同源简称(alias symbol)
基因家族代码(gene_family_id)
omim代码
entrez码
vega基因码
ensembl基因码
基因家族(gene family)
refseq数据库代号
更多...
基因种类(locus_type)
基因名称状态(status)
location_sortable
同源基因名称(alias name)
基因名称批准使用时间(date_approved_reserved)
基因简称更名时间(date_symbol_changed)
基因名称更名时间(date_name_changed)
更新时间(date_modified)
ucsc码
ena
ccds数据码
uniprot数据码
pubmed代码
mgd码
rgd码
生命科学数据库(lsdb)
更新时间(date modified)
cosmic
mirbase
基因曾用简称(prev symbol)
基因曾用名称(prev name)
homeodb
cosmic
snornabase
bioparadigms slc
orphanet
假基因信息(pseudogeneorg)
horde id
merops
imgt
iuphar
kznf基因类别
mamit-trnadb
cd
LncRNA数据库
酶代码
中间纤维数据库
收起
APOE基因的碱基突变：
显示全部snp
rs7412
rs405509
rs429358
rs434132
rs435380
rs439382
rs440446
rs446037
rs449647
rs769445
rs769446
rs769447
rs769448
rs769449
rs769450
rs769451
rs769452
rs769453
rs769454
rs769455
rs877973
rs1081101
rs1081103
rs1081105
rs1809337
rs1809338
rs2007708
rs7256173
rs7259620
rs9282609
rs11083750
rs11542029
rs11542031
rs11542037
rs11542040
rs11542041
rs12982192
rs28931576
rs28931579
rs61357706
rs66916483
rs72654460
rs72654461
rs72654462
rs72654463
rs72654464
rs72654465
rs72654466
rs72654467
rs72654468
rs79684409
rs111635202
rs111833428
rs113191942
rs115299243
rs117656888
rs117969547
rs121918392
rs121918393
rs121918395
rs121918399
rs138102896
rs139061516
rs139948786
rs140808909
rs140872744
rs141549454
rs142480126
rs143063029
rs143569527
rs144354013
rs144675659
rs145430960
rs147236548
rs148558158
rs148823871
rs148870838
rs150375400
rs150688032
rs180956217
rs183493034
rs184686013
rs186466504
rs186787041
rs187698180
rs189466561
rs189660912
rs190853081
rs191314608
rs191725650
rs192348494
rs192617074
rs199768005
rs200125743
rs201463764
rs201596692
rs201672011
rs201735361
rs267606661
rs267606663
rs267606664
rs367866106
rs368210726
rs368495194
rs368711626
rs369705950
rs370227413
rs370594287
rs371110159
rs371331933
rs371694216
rs372675300
rs372938213
rs373020952
rs373321868
rs373651604
rs373985746
rs374305692
rs374329439
rs374670655
rs375741166
rs376170967
rs376304457
rs376607258
rs377486301
rs527866428
rs527903981
rs528229851
rs529520553
rs529662056
rs529926923
rs530010303
rs530066149
rs530181424
rs530370643
rs530431608
rs531783167
rs531939919
rs532224117
rs532314089
rs532380481
rs533904656
rs534584472
rs535397097
rs536031139
rs536384937
rs537344262
rs537380977
rs537609941
rs537741299
rs538026106
rs538246559
rs538385866
rs538396896
rs538633437
rs539159437
rs539470710
rs539807928
rs539986817
rs541152874
rs541228072
rs541582259
rs542186645
rs543363163
rs543538052
rs544583447
rs544988836
rs545943117
rs546268923
rs547294441
rs547430399
rs547472686
rs549553647
rs549854089
rs549957657
rs550091545
rs550141058
rs550371899
rs550501196
rs551256627
rs551669831
rs551867359
rs552009518
rs552235600
rs552962455
rs553197505
rs553346081
rs553730037
rs553874843
rs554858657
rs555222732
rs555840707
rs555877419
rs555914310
rs556703754
rs556719594
rs556984560
rs557172708
rs557715042
rs557845700
rs558171988
rs558318331
rs559532612
rs560770492
rs561015575
rs561129890
rs561364272
rs561438755
rs561448389
rs563103121
rs563140413
rs563413650
rs563571689
rs563699746
rs564144591
rs565370015
rs565408599
rs565569107
rs565734271
rs565782572
rs566060419
rs567084204
rs567353589
rs567494601
rs567707344
rs567971502
rs568489254
rs568735371
rs569017773
rs569333472
rs569463996
rs571212925
rs571607340
rs571735137
rs572606163
rs572713679
rs573658040
rs573693195
rs574713730
rs574743850
rs576710217
rs577113356
rs577252110
rs577386185
rs577618688
rs577942151
rs587778877
rs745552623
rs745950059
rs746294588
rs746382742
rs746975744
rs747076678
rs747078681
rs747184737
rs747272511
rs747448265
rs747975000
rs748145618
rs748397288
rs748506927
rs748703149
rs748779489
rs749018009
rs749102800
rs749160976
rs749406635
rs749645156
rs749750245
rs750138933
rs750778421
rs751150968
rs751200677
rs751468484
rs752079771
rs752219259
rs752327439
rs752409518
rs752600356
rs752790054
rs753264397
rs753523910
rs753601274
rs753798476
rs753832155
rs754131538
rs754211171
rs754223652
rs754318486
rs754627330
rs755062095
rs755136353
rs755218314
rs755434388
rs755792921
rs755877232
rs756130353
rs756353413
rs756564996
rs756776560
rs756885680
rs757148922
rs757647161
rs757764781
rs757859088
rs758127435
rs758379972
rs758487955
rs758885367
rs759118026
rs759134820
rs759501381
rs759721023
rs760456587
rs760927661
rs761285934
rs761350032
rs761381769
rs761592007
rs761790162
rs761968063
rs761988169
rs762461580
rs762703669
rs762734089
rs762845923
rs762906934
rs762933906
rs763313394
rs763632507
rs763720372
rs763790607
rs764266965
rs764929617
rs765437285
rs765845034
rs766215051
rs766493265
rs766970919
rs767382895
rs767805388
rs767980905
rs768374191
rs768684471
rs768780599
rs768844640
rs768925016
rs768934589
rs768998148
rs769366285
rs770023201
rs770485817
rs770545391
rs770562611
rs770641623
rs770658351
rs770779481
rs770942678
rs771354248
rs771390880
rs771594795
rs771620473
rs772056790
rs772554321
rs772936346
rs773051326
rs773268787
rs773391883
rs773797268
rs774000134
rs774067024
rs774160308
rs774354369
rs774452222
rs776242156
rs776830091
rs777291619
rs777388107
rs777551553
rs777571029
rs778237451
rs778348297
rs778425259
rs778534804
rs778989940
rs779278130
rs779569800
rs780035531
rs780067631
rs780156942
rs780533924
rs780699141
rs780984110
rs781192562
rs781196862
rs781722239
正向引物序列
正向引物Tm值
反向引物序列
反向引物Tm值
rank
GGTTTCTAATGCATTGCAGG
58
ATAAAGATCACAGCTGCCC
58
TTTCTAATGCATTGCAGGC
57
GAATAAAGATCACAGCTGCC
57
GTTGCTGGTCACATTCCTG
59
CTCCTTCATGGTCTCGTCC
60
GTTGCTGGTCACATTCCTG
59
TCATGGTCTCGTCCATCAG
59
GTTGCTGGTCACATTCCTG
59
TTCATGGTCTCGTCCATCAG
60
TAGAAAGAGCTGGGACCCT
60
TCTTCCTGCCTGTGATTGG
60
TCTAGAAAGAGCTGGGACC
58
TCTTCCTGCCTGTGATTGG
60
GTTGCTGGTCACATTCCTG
59
TTCATGGTCTCGTCCATCAG
60
GTTGCTGGTCACATTCCTG
59
CTCCTTCATGGTCTCGTCC
60
GTTGCTGGTCACATTCCTG
59
CTCCTTCATGGTCTCGTCC
60
基因本体信息
APOE基因（以及对应的蛋白质）的细胞分布位置：
- 溶酶体
- 内涵体
- 细胞核
- 细胞质
- 液泡
- 细胞膜
- 细胞外基质
- 内质网
- 线粒体
- 高尔基体
- 细胞骨架
APOE基因的本体（GO）信息：
GO库代码
对应的蛋白质
来源代码
GO:0005576
E7ERP7(UniProtKB)
IEA
GO:0006869
E7ERP7(UniProtKB)
IEA
GO:0008289
E7ERP7(UniProtKB)
IEA
GO:0042157
E7ERP7(UniProtKB)
IEA
GO:0005576
E9PEV4(UniProtKB)
IEA
GO:0006869
E9PEV4(UniProtKB)
IEA
GO:0008289
E9PEV4(UniProtKB)
IEA
GO:0042157
E9PEV4(UniProtKB)
IEA
GO:0005576
H0Y7L5(UniProtKB)
IEA
GO:0006869
H0Y7L5(UniProtKB)
IEA
GO:0008289
H0Y7L5(UniProtKB)
IEA
GO:0042157
H0Y7L5(UniProtKB)
IEA
GO:0000302
P02649(UniProtKB)
NAS
GO:0001523
P02649(UniProtKB)
TAS
GO:0001540
P02649(UniProtKB)
IDA
GO:0001937
P02649(UniProtKB)
IDA
GO:0002021
P02649(UniProtKB)
IEA
GO:0005319
P02649(UniProtKB)
IDA
GO:0005515
P02649(UniProtKB)
IPI
GO:0005515
P02649(UniProtKB)
IPI
GO:0005515
P02649(UniProtKB)
IPI
GO:0005515
P02649(UniProtKB)
IPI
GO:0005515
P02649(UniProtKB)
IPI
GO:0005515
P02649(UniProtKB)
IPI
GO:0005515
P02649(UniProtKB)
IPI
GO:0005515
P02649(UniProtKB)
IPI
GO:0005515
P02649(UniProtKB)
IPI
GO:0005515
P02649(UniProtKB)
IPI
GO:0005515
P02649(UniProtKB)
IPI
GO:0005515
P02649(UniProtKB)
IPI
GO:0005515
P02649(UniProtKB)
IPI
GO:0005515
P02649(UniProtKB)
IPI
GO:0005515
P02649(UniProtKB)
IPI
GO:0005515
P02649(UniProtKB)
IPI
GO:0005543
P02649(UniProtKB)
IDA
GO:0005576
P02649(UniProtKB)
TAS
GO:0005576
P02649(UniProtKB)
TAS
GO:0005576
P02649(UniProtKB)
TAS
GO:0005576
P02649(UniProtKB)
TAS
GO:0005576
P02649(UniProtKB)
TAS
GO:0005576
P02649(UniProtKB)
TAS
GO:0005576
P02649(UniProtKB)
TAS
GO:0005576
P02649(UniProtKB)
TAS
GO:0005576
P02649(UniProtKB)
TAS
GO:0005576
P02649(UniProtKB)
TAS
GO:0005576
P02649(UniProtKB)
TAS
GO:0005615
P02649(UniProtKB)
IDA
GO:0005615
P02649(UniProtKB)
IDA
GO:0005634
P02649(UniProtKB)
IDA
GO:0005737
P02649(UniProtKB)
NAS
GO:0005737
P02649(UniProtKB)
TAS
GO:0005769
P02649(UniProtKB)
TAS
GO:0005769
P02649(UniProtKB)
TAS
GO:0005769
P02649(UniProtKB)
TAS
GO:0005783
P02649(UniProtKB)
IDA
GO:0005794
P02649(UniProtKB)
IDA
GO:0005886
P02649(UniProtKB)
TAS
GO:0006641
P02649(UniProtKB)
IMP
GO:0006641
P02649(UniProtKB)
IDA
GO:0006707
P02649(UniProtKB)
IBA
GO:0006874
P02649(UniProtKB)
IEA
GO:0006898
P02649(UniProtKB)
IDA
GO:0006898
P02649(UniProtKB)
TAS
GO:0006898
P02649(UniProtKB)
TAS
GO:0007010
P02649(UniProtKB)
TAS
GO:0007186
P02649(UniProtKB)
IDA
GO:0007263
P02649(UniProtKB)
IDA
GO:0007271
P02649(UniProtKB)
TAS
GO:0008201
P02649(UniProtKB)
IDA
GO:0008203
P02649(UniProtKB)
IMP
GO:0008203
P02649(UniProtKB)
IDA
GO:0008289
P02649(UniProtKB)
IDA
GO:0010468
P02649(UniProtKB)
IEA
GO:0010544
P02649(UniProtKB)
IDA
GO:0010873
P02649(UniProtKB)
IDA
GO:0010875
P02649(UniProtKB)
IDA
GO:0010875
P02649(UniProtKB)
IGI
GO:0010875
P02649(UniProtKB)
IDA
GO:0015485
P02649(UniProtKB)
IBA
GO:0015909
P02649(UniProtKB)
IDA
GO:0016020
P02649(UniProtKB)
IDA
GO:0016209
P02649(UniProtKB)
IDA
GO:0017038
P02649(UniProtKB)
IDA
GO:0017127
P02649(UniProtKB)
IBA
GO:0019068
P02649(UniProtKB)
IMP
GO:0019433
P02649(UniProtKB)
IBA
GO:0019934
P02649(UniProtKB)
IDA
GO:0030195
P02649(UniProtKB)
IDA
GO:0030425
P02649(UniProtKB)
NAS
GO:0030516
P02649(UniProtKB)
TAS
GO:0030828
P02649(UniProtKB)
IDA
GO:0031012
P02649(UniProtKB)
IDA
GO:0031102
P02649(UniProtKB)
IBA
GO:0032489
P02649(UniProtKB)
IDA
GO:0032805
P02649(UniProtKB)
IDA
GO:0033344
P02649(UniProtKB)
IDA
GO:0033344
P02649(UniProtKB)
IDA
GO:0033700
P02649(UniProtKB)
IDA
GO:0034361
P02649(UniProtKB)
IDA
GO:0034361
P02649(UniProtKB)
IDA
GO:0034362
P02649(UniProtKB)
IDA
GO:0034363
P02649(UniProtKB)
IDA
GO:0034364
P02649(UniProtKB)
IDA
GO:0034372
P02649(UniProtKB)
IGI
GO:0034372
P02649(UniProtKB)
IDA
GO:0034374
P02649(UniProtKB)
IEA
GO:0034375
P02649(UniProtKB)
IGI
GO:0034380
P02649(UniProtKB)
IDA
GO:0034382
P02649(UniProtKB)
IMP
GO:0034384
P02649(UniProtKB)
IDA
GO:0034447
P02649(UniProtKB)
IDA
GO:0034447
P02649(UniProtKB)
IMP
GO:0042157
P02649(UniProtKB)
TAS
GO:0042157
P02649(UniProtKB)
TAS
GO:0042158
P02649(UniProtKB)
IEA
GO:0042159
P02649(UniProtKB)
IBA
GO:0042159
P02649(UniProtKB)
TAS
GO:0042311
P02649(UniProtKB)
IEA
GO:0042627
P02649(UniProtKB)
IDA
GO:0042627
P02649(UniProtKB)
IDA
GO:0042632
P02649(UniProtKB)
IDA
GO:0042802
P02649(UniProtKB)
IDA
GO:0042803
P02649(UniProtKB)
IPI
GO:0043025
P02649(UniProtKB)
NAS
GO:0043407
P02649(UniProtKB)
IDA
GO:0043524
P02649(UniProtKB)
IBA
GO:0043537
P02649(UniProtKB)
IDA
GO:0043691
P02649(UniProtKB)
IDA
GO:0044794
P02649(UniProtKB)
IMP
GO:0045541
P02649(UniProtKB)
IDA
GO:0046889
P02649(UniProtKB)
IDA
GO:0046907
P02649(UniProtKB)
TAS
GO:0046911
P02649(UniProtKB)
IDA
GO:0048156
P02649(UniProtKB)
IPI
GO:0048168
P02649(UniProtKB)
TAS
GO:0048844
P02649(UniProtKB)
IEA
GO:0050728
P02649(UniProtKB)
IC
GO:0050750
P02649(UniProtKB)
IPI
GO:0050750
P02649(UniProtKB)
IDA
GO:0051000
P02649(UniProtKB)
IDA
GO:0051044
P02649(UniProtKB)
IDA
GO:0051055
P02649(UniProtKB)
IDA
GO:0051651
P02649(UniProtKB)
IEA
GO:0055089
P02649(UniProtKB)
IDA
GO:0060228
P02649(UniProtKB)
IDA
GO:0060999
P02649(UniProtKB)
IDA
GO:0061000
P02649(UniProtKB)
IDA
GO:0070062
P02649(UniProtKB)
IDA
GO:0070062
P02649(UniProtKB)
IDA
GO:0070062
P02649(UniProtKB)
IDA
GO:0070062
P02649(UniProtKB)
IDA
GO:0070326
P02649(UniProtKB)
IPI
GO:0070326
P02649(UniProtKB)
IDA
GO:0071682
P02649(UniProtKB)
TAS
GO:0071813
P02649(UniProtKB)
IEA
GO:0072562
P02649(UniProtKB)
IDA
GO:0090090
P02649(UniProtKB)
TAS
GO:0090370
P02649(UniProtKB)
IDA
GO:0097113
P02649(UniProtKB)
IDA
GO:0097114
P02649(UniProtKB)
IDA
GO:0098869
P02649(UniProtKB)
IEA
GO:1900221
P02649(UniProtKB)
IDA
GO:1901214
P02649(UniProtKB)
IDA
GO:1901215
P02649(UniProtKB)
IDA
GO:1901216
P02649(UniProtKB)
IDA
GO:1901627
P02649(UniProtKB)
IDA
GO:1901628
P02649(UniProtKB)
IDA
GO:1901630
P02649(UniProtKB)
IDA
GO:1901631
P02649(UniProtKB)
IDA
GO:1902004
P02649(UniProtKB)
IDA
GO:1902004
P02649(UniProtKB)
IDA
GO:1902430
P02649(UniProtKB)
IDA
GO:1902430
P02649(UniProtKB)
IDA
GO:1902947
P02649(UniProtKB)
IDA
GO:1902951
P02649(UniProtKB)
IDA
GO:1902952
P02649(UniProtKB)
IDA
GO:1902995
P02649(UniProtKB)
IDA
GO:1902998
P02649(UniProtKB)
IDA
GO:1902999
P02649(UniProtKB)
IDA
GO:1903001
P02649(UniProtKB)
IDA
GO:1903002
P02649(UniProtKB)
IDA
GO:1903561
P02649(UniProtKB)
IDA
| 疾病名称 | 关系值 | NofPmids | NofSnps | 来源 |
| LIPOPROTEIN GLOMERULOPATHY | 0.493963088 | 34 | 2 | BeFree_CLINVAR_CTD_human_GAD_ORPHANET_UNIPROT |
| Alzheimer's Disease | 0.44 | 1226 | 22 | BeFree_CTD_human_GAD_LHGDN_RGD |
| Hyperlipoproteinemia Type III | 0.391031588 | 68 | 16 | BeFree_CLINVAR_CTD_human_GAD_ORPHANET |
| Sea-Blue Histiocyte Syndrome | 0.36 | 1 | 1 | CLINVAR_CTD_human_ORPHANET |
| Myocardial Infarction | 0.340397866 | 55 | 3 | BeFree_CLINVAR_CTD_human_GAD_LHGDN |
| Hyperlipidemia | 0.303112285 | 87 | 0 | BeFree_CTD_human_GAD_LHGDN_RGD |
| Atherosclerosis | 0.301890017 | 322 | 1 | BeFree_CTD_human_GAD_LHGDN |
| Hypertensive disease | 0.291129117 | 71 | 1 | BeFree_CTD_human_GAD_RGD |
| Coronary heart disease | 0.259776801 | 193 | 4 | BeFree_CTD_human_GAD_LHGDN |
| Schizophrenia | 0.250083515 | 39 | 0 | BeFree_CTD_human_GAD_LHGDN_RGD |
| Cardiovascular Diseases | 0.243208915 | 158 | 5 | BeFree_CTD_human_GAD_LHGDN |
| Multiple Sclerosis | 0.233456871 | 67 | 0 | BeFree_CTD_human_GAD_LHGDN |
| Dementia | 0.228108756 | 497 | 2 | BeFree_GAD_LHGDN |
| Arteriosclerosis | 0.207296 | 283 | 1 | BeFree_CTD_human_GAD |
| Hypercholesterolemia | 0.201659325 | 70 | 2 | BeFree_CTD_human_GAD_LHGDN |
| Impaired cognition | 0.199576076 | 270 | 7 | BeFree_GAD_GWASCAT |
| Obesity | 0.195505919 | 54 | 8 | BeFree_CTD_human_GAD |
| Age related macular degeneration | 0.195200801 | 56 | 4 | BeFree_CTD_human_GAD_LHGDN |
| Cerebral Amyloid Angiopathy | 0.167153736 | 58 | 0 | BeFree_CTD_human_GAD_LHGDN |
| Lewy Body Disease | 0.142431324 | 33 | 1 | BeFree_GAD_GWASCAT_LHGDN |
| Carotid Artery Diseases | 0.137926433 | 11 | 2 | BeFree_CTD_human_GAD |
| Hypercholesterolemia, Familial | 0.137535439 | 26 | 0 | BeFree_CTD_human_GAD |
| Carotid Stenosis | 0.130282454 | 6 | 0 | BeFree_CTD_human_GAD |
| Psoriasis | 0.128729747 | 6 | 0 | BeFree_CTD_human_GAD |
| Amyloidosis | 0.127991366 | 15 | 0 | BeFree_CTD_human_GAD |
| Nerve Degeneration | 0.127101096 | 4 | 0 | CTD_human_GAD |
| Hyperlipoproteinemias | 0.126981544 | 18 | 1 | BeFree_CLINVAR_GAD |
| Seizures | 0.126905599 | 9 | 0 | BeFree_CTD_human_GAD |
| Coronary Artery Disease | 0.12550827 | 108 | 4 | BeFree_GAD_LHGDN |
| Cognition Disorders | 0.125276948 | 5 | 0 | BeFree_CTD_human_GAD |
| Lung Neoplasms | 0.12272435 | 3 | 0 | CTD_human_LHGDN |
| Multiple Sclerosis, Relapsing-Remitting | 0.122638474 | 2 | 0 | BeFree_CTD_human_GAD |
| Spontaneous abortion | 0.122367032 | 2 | 0 | CTD_human_GAD |
| Hepatolenticular Degeneration | 0.122367032 | 2 | 0 | CTD_human_GAD |
| Mental deterioration | 0.122367032 | 2 | 1 | GAD_GWASCAT |
| ALZHEIMER DISEASE 2 | 0.121085767 | 4 | 0 | BeFree_CTD_human |
| Adenocarcinoma | 0.120271442 | 2 | 0 | BeFree_CTD_human |
| Renal Insufficiency | 0.120271442 | 2 | 0 | BeFree_CTD_human |
| Pathological accumulation of air in tissues | 0.12 | 1 | 0 | CTD_human |
| Mercury Poisoning | 0.12 | 1 | 0 | CTD_human |
| Proteinuria | 0.12 | 1 | 0 | CTD_human |
| Splenomegaly | 0.12 | 1 | 0 | CTD_human |
| Drug-Induced Liver Injury | 0.12 | 1 | 0 | CTD_human |
| hearing impairment | 0.12 | 1 | 0 | CTD_human |
| CORONARY ARTERY DISEASE, SEVERE, SUSCEPTIBILITY TO | 0.12 | 0 | 1 | CLINVAR |
| Macular Degeneration, Age-Related, 1 | 0.12 | 0 | 0 | CTD_human |
| Plaque, Atherosclerotic | 0.12 | 5 | 0 | CTD_human |
| Cerebrovascular accident | 0.114502912 | 123 | 3 | BeFree_GAD_LHGDN |
| Diabetes Mellitus, Non-Insulin-Dependent | 0.106369588 | 99 | 0 | BeFree_GAD_LHGDN |
| Hyperhomocysteinemia | 0.093821129 | 10 | 1 | BeFree_GAD_LHGDN_RGD |
| Transient Ischemic Attack | 0.086634157 | 10 | 0 | BeFree_GAD_RGD |
| Infarction, Middle Cerebral Artery | 0.084734064 | 3 | 0 | GAD_RGD |
| Non-alcoholic Fatty Liver Disease | 0.081085767 | 5 | 0 | BeFree_RGD |
| Memory Disorders | 0.080542884 | 47 | 0 | BeFree_GAD |
| Membranous glomerulonephritis | 0.080271442 | 2 | 0 | BeFree_RGD |
| Parkinson Disease | 0.080074281 | 34 | 0 | BeFree_GAD_LHGDN |
| Presenile dementia | 0.08 | 416 | 2 | BeFree |
| Diabetes Mellitus, Experimental | 0.08 | 1 | 0 | RGD |
| Pancreatic Neoplasm | 0.08 | 1 | 0 | RGD |
| Sciatic Neuropathy | 0.08 | 1 | 0 | RGD |
| Dementia, Vascular | 0.070704504 | 74 | 5 | BeFree_GAD_LHGDN |
| Coronary Arteriosclerosis | 0.06904472 | 154 | 3 | BeFree_GAD |
| Brain Ischemia | 0.061814273 | 27 | 0 | BeFree_GAD |
| Hypertriglyceridemia | 0.058952677 | 22 | 0 | GAD_LHGDN |
| Atrophic | 0.054799054 | 22 | 0 | GAD_LHGDN |
| Subarachnoid Hemorrhage | 0.054655757 | 27 | 0 | BeFree_GAD_LHGDN |
| Cerebral Hemorrhage | 0.051136945 | 19 | 0 | GAD_LHGDN |
| Myocardial Ischemia | 0.049478499 | 32 | 0 | BeFree_GAD_LHGDN |
| Mental Depression | 0.048610634 | 64 | 2 | BeFree_GAD |
| Diabetic Nephropathy | 0.04581639 | 27 | 0 | BeFree_GAD_LHGDN |
| Neurodegenerative Disorders | 0.044838905 | 74 | 0 | BeFree_GAD_LHGDN |
| Hypertriglyceridemia result | 0.042606576 | 18 | 0 | GAD |
| Mild cognitive disorder | 0.040021507 | 131 | 2 | BeFree_GAD |
| Dyslipidemias | 0.035957268 | 44 | 2 | BeFree_GAD_LHGDN |
| Cerebrovascular Disorders | 0.035862798 | 14 | 0 | GAD_LHGDN |
| Metabolic Syndrome X | 0.032009073 | 28 | 3 | BeFree_GAD |
| Diabetes Mellitus | 0.031965466 | 54 | 0 | BeFree_GAD |
| Glaucoma, Open-Angle | 0.030733859 | 11 | 0 | BeFree_GAD_LHGDN |
| Down Syndrome | 0.030270801 | 28 | 1 | BeFree_GAD_LHGDN |
| Cerebral Infarction | 0.029466407 | 16 | 1 | BeFree_GAD_LHGDN |
| Senile Plaques | 0.025439591 | 86 | 5 | BeFree_GAD |
| Cholelithiasis | 0.024832032 | 19 | 1 | BeFree_GAD |
| HIV Infections | 0.024365093 | 22 | 0 | BeFree_GAD |
| Vascular Diseases | 0.024245541 | 42 | 1 | BeFree_GAD |
| Epilepsy, Temporal Lobe | 0.024103583 | 12 | 1 | BeFree_GAD_LHGDN |
| Colorectal Cancer | 0.022389055 | 10 | 0 | BeFree_GAD |
| Diabetes Mellitus, Insulin-Dependent | 0.021922116 | 15 | 0 | BeFree_GAD |
| Nephrotic Syndrome | 0.021550985 | 9 | 0 | BeFree_GAD_LHGDN |
| Postoperative Complications | 0.021303288 | 9 | 0 | GAD |
| Delirium | 0.019369519 | 10 | 0 | BeFree_GAD_LHGDN |
| Inflammation | 0.018936256 | 8 | 0 | GAD |
| Alzheimer Disease, Late Onset | 0.018729489 | 69 | 3 | BeFree |
| Kidney Failure, Chronic | 0.018469317 | 12 | 0 | BeFree_GAD |
| Sleep Apnea, Obstructive | 0.018174131 | 12 | 0 | BeFree_GAD_LHGDN |
| Ischemic stroke | 0.017958771 | 42 | 1 | BeFree_GAD |
| Amyotrophic Lateral Sclerosis | 0.017459494 | 16 | 0 | BeFree_GAD |
| Disease Progression | 0.016569224 | 7 | 0 | GAD |
| Depressive disorder | 0.01601507 | 59 | 2 | BeFree |
| Plaque, Amyloid | 0.015863181 | 43 | 0 | BeFree_GAD |
| Fatty Liver | 0.015731154 | 6 | 0 | BeFree_GAD_LHGDN |
| Neurofibrillary degeneration (morphologic abnormality) | 0.015472187 | 57 | 1 | BeFree |
| Ischemia | 0.015264215 | 14 | 0 | BeFree_GAD_LHGDN |
| Congenital Heart Defects | 0.015016517 | 7 | 0 | BeFree_GAD |
| Hyperlipidemia, Familial Combined | 0.014992773 | 12 | 5 | BeFree_GAD_LHGDN |
| Cholecystolithiasis | 0.014549579 | 14 | 0 | BeFree_GAD |
| Heart Diseases | 0.014364013 | 13 | 0 | BeFree_GAD_LHGDN |
| Amnesia | 0.014006695 | 13 | 0 | BeFree_GAD |
| Memory impairment | 0.013963088 | 36 | 0 | BeFree_GAD |
| AURAL ATRESIA, CONGENITAL | 0.013572094 | 50 | 0 | BeFree |
| Liver Cirrhosis | 0.013006804 | 6 | 0 | BeFree_GAD_LHGDN |
| Alcoholic Intoxication, Chronic | 0.012920927 | 6 | 0 | BeFree_GAD |
| Colorectal Neoplasms | 0.01246392 | 5 | 0 | BeFree_GAD_LHGDN |
| Intracranial Arteriosclerosis | 0.012192478 | 5 | 0 | GAD_LHGDN |
| Angina Pectoris | 0.01183516 | 5 | 0 | GAD |
| Pre-Eclampsia | 0.01183516 | 5 | 0 | GAD |
| Cerebral Palsy | 0.011368221 | 9 | 0 | BeFree_GAD |
| Lupus Erythematosus, Systemic | 0.011268532 | 6 | 0 | BeFree_GAD_LHGDN |
| Diabetes | 0.010857675 | 40 | 0 | BeFree |
| Depressive Symptoms | 0.01078173 | 31 | 2 | BeFree_GAD |
| Kidney Diseases | 0.010705785 | 24 | 2 | BeFree_GAD |
| Hepatitis C, Chronic | 0.010553895 | 7 | 0 | BeFree_GAD |
| Hepatitis C | 0.010444275 | 13 | 0 | BeFree_GAD_LHGDN |
| Malignant neoplasm of breast | 0.010086957 | 12 | 0 | BeFree_GAD |
| Osteoporosis | 0.009815515 | 11 | 0 | BeFree_GAD |
| Insulin Resistance | 0.009468128 | 4 | 0 | GAD |
| Intracranial Hemorrhages | 0.009468128 | 4 | 0 | GAD |
| Complications of Diabetes Mellitus | 0.009468128 | 4 | 1 | GAD |
| Olfaction Disorders | 0.009468128 | 4 | 0 | GAD |
| nervous system disorder | 0.009077134 | 18 | 0 | BeFree_GAD |
| Kidney Failure | 0.009001189 | 9 | 0 | BeFree_GAD |
| Cerebral atrophy | 0.008957582 | 33 | 0 | BeFree |
| Ischemic Cerebrovascular Accident | 0.008957582 | 33 | 0 | BeFree |
| Primary Progressive Aphasia (disorder) | 0.008729747 | 9 | 2 | BeFree_GAD |
| Congenital arteriovenous malformation | 0.008544182 | 4 | 0 | BeFree_GAD_LHGDN |
| Carotid Atherosclerosis | 0.00853425 | 15 | 0 | BeFree_GAD |
| Acute Coronary Syndrome | 0.008186863 | 7 | 0 | BeFree_GAD |
| Infection | 0.008173051 | 3 | 0 | LHGDN |
| Pick Disease of the Brain | 0.008067311 | 22 | 0 | BeFree_GAD |
| Lipid Metabolism Disorders | 0.007915422 | 5 | 0 | BeFree_GAD |
| Coronary Stenosis | 0.007915422 | 6 | 0 | BeFree_GAD |
| Mammary Neoplasms | 0.007815732 | 3 | 0 | GAD_LHGDN |
| Diabetic Retinopathy | 0.00764398 | 4 | 0 | BeFree_GAD |
| Hemorrhage | 0.007458414 | 3 | 0 | GAD_LHGDN |
| Intracranial Aneurysm | 0.007372538 | 4 | 0 | BeFree_GAD |
| Frontotemporal dementia | 0.007252986 | 18 | 0 | BeFree_GAD |
| Major Depressive Disorder | 0.007177041 | 10 | 0 | BeFree_GAD |
| Chronic Obstructive Airway Disease | 0.007101096 | 3 | 0 | GAD |
| Osteoporosis, Postmenopausal | 0.007101096 | 3 | 0 | GAD |
| Pancreatitis | 0.007101096 | 3 | 0 | GAD |
| Psychomotor Disorders | 0.007101096 | 3 | 0 | GAD |
| Thrombosis | 0.007101096 | 3 | 0 | GAD |
| Vasospasm, Intracranial | 0.007101096 | 3 | 0 | GAD |
| Brain Infarction | 0.007101096 | 3 | 0 | GAD |
| WARFARIN SENSITIVITY (disorder) | 0.007101096 | 3 | 0 | GAD |
| Sleep Apnea Syndromes | 0.006905599 | 8 | 0 | BeFree_GAD |
| Inclusion Body Myositis (disorder) | 0.006448592 | 6 | 0 | BeFree_GAD_LHGDN |
| Glaucoma | 0.006362715 | 7 | 0 | BeFree_GAD |
| Malaria | 0.006263026 | 4 | 0 | BeFree_LHGDN |
| Cognitive changes | 0.006243163 | 23 | 3 | BeFree |
| Rheumatoid Arthritis | 0.00617715 | 5 | 0 | BeFree_GAD_LHGDN |
| Autistic Disorder | 0.00617715 | 5 | 0 | BeFree_GAD_LHGDN |
| AIDS Dementia Complex | 0.005819831 | 6 | 0 | BeFree_GAD |
| Agitation | 0.005819831 | 6 | 0 | BeFree_GAD |
| Migraine Disorders | 0.005819831 | 4 | 0 | BeFree_GAD |
| Exfoliation Syndrome | 0.005819831 | 4 | 0 | BeFree_GAD |
| Aortic Valve Stenosis | 0.005634266 | 3 | 0 | BeFree_GAD_LHGDN |
| Febrile Convulsions | 0.005634266 | 2 | 0 | BeFree_GAD_LHGDN |
| Encephalitis | 0.005634266 | 4 | 0 | BeFree_GAD_LHGDN |
| Hypoglycemia | 0.005634266 | 2 | 0 | BeFree_GAD_LHGDN |
| Tetralogy of Fallot | 0.005634266 | 2 | 0 | BeFree_GAD_LHGDN |
| Progressive supranuclear palsy | 0.005624334 | 12 | 0 | BeFree_GAD |
| Diabetic Neuropathies | 0.00554839 | 3 | 0 | BeFree_GAD |
| Polycystic Ovary Syndrome | 0.00554839 | 3 | 0 | BeFree_GAD |
| Mixed hyperlipidemia (disorder) | 0.00554839 | 5 | 0 | BeFree_GAD |
| Focal glomerulosclerosis | 0.005362824 | 1 | 0 | BeFree_GAD_LHGDN |
| Compression of spinal cord | 0.005362824 | 1 | 0 | BeFree_GAD_LHGDN |
| Sudden infant death syndrome | 0.005362824 | 1 | 0 | BeFree_GAD_LHGDN |
| Alcohol Withdrawal Seizures | 0.005362824 | 1 | 0 | BeFree_GAD_LHGDN |
| Hepatitis B | 0.005276948 | 3 | 0 | BeFree_GAD |
| Liver Cirrhosis, Alcoholic | 0.005276948 | 2 | 0 | BeFree_GAD |
| Tension Headache | 0.005276948 | 2 | 0 | BeFree_GAD |
| Chronic Kidney Insufficiency | 0.005276948 | 4 | 0 | BeFree_GAD |
| Sleep Disorders | 0.005276948 | 4 | 0 | BeFree_GAD |
| Anoxia | 0.005091382 | 2 | 0 | GAD_LHGDN |
| Fetal Growth Retardation | 0.005091382 | 2 | 0 | GAD_LHGDN |
| Hepatitis | 0.005091382 | 2 | 0 | GAD_LHGDN |
| Spina Bifida Cystica | 0.005091382 | 1 | 0 | GAD_LHGDN |
| Polycystic Kidney, Autosomal Dominant | 0.005091382 | 1 | 0 | GAD_LHGDN |
| Herpes Simplex Infections | 0.005081451 | 11 | 0 | BeFree_GAD |
| Frontotemporal Lobar Degeneration | 0.005081451 | 10 | 0 | BeFree_GAD |
| Adenoma | 0.005005506 | 3 | 0 | BeFree_GAD |
| Anemia, Sickle Cell | 0.005005506 | 3 | 0 | BeFree_GAD |
| Angina, Unstable | 0.005005506 | 3 | 0 | BeFree_GAD |
| beta Thalassemia | 0.005005506 | 3 | 0 | BeFree_GAD |
| Genital Herpes | 0.005005506 | 2 | 0 | BeFree_GAD |
| Hyperinsulinism | 0.005005506 | 3 | 0 | BeFree_GAD |
| Hypothyroidism | 0.005005506 | 2 | 0 | BeFree_GAD |
| Herpes encephalitis | 0.005005506 | 2 | 0 | BeFree_GAD |
| Brain Edema | 0.005005506 | 2 | 0 | BeFree_GAD |
| Creutzfeldt-Jakob disease | 0.004810009 | 9 | 0 | BeFree_GAD |
| Aphasia | 0.004734064 | 2 | 0 | GAD |
| Atrial Fibrillation | 0.004734064 | 2 | 0 | GAD |
| Calcinosis | 0.004734064 | 2 | 0 | GAD |
| Colonic Neoplasms | 0.004734064 | 2 | 0 | GAD |
| Confusion | 0.004734064 | 2 | 0 | GAD |
| Premature Obstetric Labor | 0.004734064 | 2 | 0 | GAD |
| Learning Disorders | 0.004734064 | 2 | 0 | GAD |
| Pregnancy Complications | 0.004734064 | 2 | 0 | GAD |
| Sclerosis | 0.004734064 | 2 | 0 | GAD |
| Sensation Disorders | 0.004734064 | 2 | 0 | GAD |
| Tooth Loss | 0.004734064 | 2 | 0 | GAD |
| Aneurysm, Ruptured | 0.004734064 | 2 | 0 | GAD |
| Ventricular Dysfunction, Left | 0.004734064 | 2 | 0 | GAD |
| Subarachnoid Hemorrhage, Aneurysmal | 0.004734064 | 2 | 0 | GAD |
| Hypoxia-Ischemia, Brain | 0.004734064 | 2 | 0 | GAD |
| Coronary Restenosis | 0.004734064 | 2 | 0 | GAD |
| Systemic arterial pressure | 0.004734064 | 2 | 0 | GAD |
| Hypotension Adverse Event | 0.004734064 | 2 | 0 | GAD |
| Psychomotor Agitation | 0.004734064 | 2 | 0 | GAD |
| Liver carcinoma | 0.004624443 | 8 | 0 | BeFree_LHGDN |
| Epilepsy | 0.004267125 | 7 | 0 | BeFree_GAD |
| Glaucoma, Primary Open Angle | 0.004071628 | 15 | 0 | BeFree |
| Post-Traumatic Stress Disorder | 0.003810118 | 4 | 0 | BeFree_LHGDN |
| Mental disorders | 0.003724241 | 5 | 0 | BeFree_GAD |
| CNS disorder | 0.003724241 | 6 | 0 | BeFree_GAD |
| Hallucinations | 0.003724241 | 6 | 0 | BeFree_GAD |
| Huntington Disease | 0.003724241 | 5 | 0 | BeFree_GAD |
| Prion Diseases | 0.003724241 | 6 | 0 | BeFree_GAD |
| Restenosis | 0.003724241 | 6 | 0 | BeFree_GAD |
| Hypobetalipoproteinemias | 0.003538676 | 3 | 0 | BeFree_LHGDN |
| Motor Neuron Disease | 0.003538676 | 4 | 0 | BeFree_LHGDN |
| Herpes Labialis | 0.003452799 | 5 | 0 | BeFree_GAD |
| Obesity, Abdominal | 0.003452799 | 5 | 0 | BeFree_GAD |
| Malnutrition | 0.003267234 | 2 | 0 | BeFree_LHGDN |
| Amyloid angiopathy | 0.003257302 | 12 | 0 | BeFree |
| Brain Diseases | 0.003181358 | 4 | 0 | BeFree_GAD |
| Mitral Valve Stenosis | 0.003181358 | 4 | 0 | BeFree_GAD |
| Xanthomatosis | 0.003181358 | 4 | 0 | BeFree_GAD |
| Dyskinetic syndrome | 0.002995792 | 2 | 0 | BeFree_LHGDN |
| Hemochromatosis | 0.002995792 | 2 | 2 | BeFree_LHGDN |
| leukemia | 0.002995792 | 2 | 0 | BeFree_LHGDN |
| Prostatic Neoplasms | 0.002995792 | 2 | 0 | BeFree_LHGDN |
| Macular retinal edema | 0.002995792 | 1 | 0 | BeFree_LHGDN |
| Familial Alzheimer Disease (FAD) | 0.002985861 | 11 | 0 | BeFree |
| Breast Carcinoma | 0.002985861 | 11 | 0 | BeFree |
| Acquired Immunodeficiency Syndrome | 0.002909916 | 2 | 0 | BeFree_GAD |
| Ulcerative Colitis | 0.002909916 | 2 | 0 | BeFree_GAD |
| Gall Bladder Diseases | 0.002909916 | 2 | 0 | BeFree_GAD |
| Kidney Failure, Acute | 0.002909916 | 2 | 0 | BeFree_GAD |
| Chronic Lymphocytic Leukemia | 0.002909916 | 2 | 0 | BeFree_GAD |
| Lymphoma | 0.002909916 | 2 | 0 | BeFree_GAD |
| Myopathy | 0.002909916 | 3 | 0 | BeFree_GAD |
| Peripheral Neuropathy | 0.002909916 | 3 | 0 | BeFree_GAD |
| Smith-Lemli-Opitz Syndrome | 0.002909916 | 2 | 0 | BeFree_GAD |
| Malignant neoplasm of lung | 0.002909916 | 3 | 0 | BeFree_GAD |
| Malignant neoplasm of prostate | 0.002909916 | 3 | 0 | BeFree_GAD |
| Mood Disorders | 0.002909916 | 3 | 0 | BeFree_GAD |
| Bile Duct Neoplasms | 0.00272435 | 1 | 0 | LHGDN |
| Cessation of life | 0.00272435 | 1 | 0 | LHGDN |
| Dermatomycoses | 0.00272435 | 1 | 0 | LHGDN |
| Pulmonary Hypertension | 0.00272435 | 1 | 0 | LHGDN |
| Stomach Neoplasms | 0.00272435 | 1 | 0 | LHGDN |
| ovarian neoplasm | 0.00272435 | 1 | 0 | LHGDN |
| Leukoaraiosis | 0.00272435 | 1 | 0 | LHGDN |
| Stenosis | 0.00272435 | 1 | 0 | LHGDN |
| Psychotic Disorders | 0.002714419 | 10 | 0 | BeFree |
| Behcet Syndrome | 0.002638474 | 1 | 0 | BeFree_GAD |
| Renal Cell Carcinoma | 0.002638474 | 1 | 0 | BeFree_GAD |
| Cardiomyopathy, Dilated | 0.002638474 | 1 | 0 | BeFree_GAD |
| Cytomegalovirus Infections | 0.002638474 | 1 | 0 | BeFree_GAD |
| Diabetic Angiopathies | 0.002638474 | 2 | 0 | BeFree_GAD |
| Fatigue | 0.002638474 | 1 | 0 | BeFree_GAD |
| Glioblastoma | 0.002638474 | 2 | 0 | BeFree_GAD |
| Glomerulonephritis | 0.002638474 | 2 | 0 | BeFree_GAD |
| Guillain-Barre Syndrome | 0.002638474 | 1 | 0 | BeFree_GAD |
| Sensorineural Hearing Loss (disorder) | 0.002638474 | 1 | 0 | BeFree_GAD |
| Cardiac Arrest | 0.002638474 | 1 | 0 | BeFree_GAD |
| Hyperlipoproteinemia Type IV | 0.002638474 | 2 | 0 | BeFree_GAD |
| Hypopituitarism | 0.002638474 | 1 | 0 | BeFree_GAD |
| Inflammatory Bowel Diseases | 0.002638474 | 2 | 0 | BeFree_GAD |
| Ketosis | 0.002638474 | 2 | 0 | BeFree_GAD |
| Metabolic Diseases | 0.002638474 | 2 | 0 | BeFree_GAD |
| Myasthenia Gravis | 0.002638474 | 1 | 0 | BeFree_GAD |
| Pulmonary Embolism | 0.002638474 | 2 | 0 | BeFree_GAD |
| Rett Syndrome | 0.002638474 | 1 | 0 | BeFree_GAD |
| Spinal Cord Diseases | 0.002638474 | 1 | 0 | BeFree_GAD |
| Stomatitis, Herpetic | 0.002638474 | 1 | 0 | BeFree_GAD |
| Trisomy | 0.002638474 | 2 | 0 | BeFree_GAD |
| Peripheral Vascular Diseases | 0.002638474 | 2 | 0 | BeFree_GAD |
| Alcohol abuse | 0.002638474 | 2 | 0 | BeFree_GAD |
| Cataract | 0.002638474 | 1 | 0 | BeFree_GAD |
| CADASIL Syndrome | 0.002638474 | 1 | 0 | BeFree_GAD |
| Aneurysm | 0.002442977 | 9 | 0 | BeFree |
| Aortic Aneurysm | 0.002442977 | 9 | 0 | BeFree |
| Unipolar Depression | 0.002442977 | 9 | 0 | BeFree |
| Nonorganic psychosis | 0.002442977 | 9 | 0 | BeFree |
| Congenital Abnormality | 0.002367032 | 1 | 0 | GAD |
| Albuminuria | 0.002367032 | 1 | 0 | GAD |
| Alcohol Amnestic Disorder | 0.002367032 | 1 | 0 | GAD |
| Biliary Tract Neoplasm | 0.002367032 | 1 | 0 | GAD |
| Malignant neoplasm of urinary bladder | 0.002367032 | 1 | 0 | GAD |
| Metabolic Bone Disorder | 0.002367032 | 1 | 0 | GAD |
| Brain Damage, Chronic | 0.002367032 | 1 | 0 | GAD |
| Cutaneous Candidiasis | 0.002367032 | 1 | 0 | GAD |
| Carbon Monoxide Poisoning | 0.002367032 | 1 | 0 | GAD |
| Carotid Artery Thrombosis | 0.002367032 | 1 | 0 | GAD |
| Cellulitis | 0.002367032 | 1 | 0 | GAD |
| Intrahepatic Cholestasis | 0.002367032 | 1 | 0 | GAD |
| Chorioamnionitis | 0.002367032 | 1 | 0 | GAD |
| Choroid Diseases | 0.002367032 | 1 | 0 | GAD |
| Chromosome Aberrations | 0.002367032 | 1 | 0 | GAD |
| Cross Infection | 0.002367032 | 1 | 0 | GAD |
| Diarrhea | 0.002367032 | 1 | 0 | GAD |
| Infantile Diarrhea | 0.002367032 | 1 | 0 | GAD |
| Drug toxicity | 0.002367032 | 1 | 0 | GAD |
| Dystonia | 0.002367032 | 1 | 0 | GAD |
| Edema | 0.002367032 | 1 | 0 | GAD |
| Epilepsy, Post-Traumatic | 0.002367032 | 1 | 0 | GAD |
| Exophthalmos | 0.002367032 | 1 | 0 | GAD |
| Fetal Diseases | 0.002367032 | 1 | 0 | GAD |
| Fetal Membranes, Premature Rupture | 0.002367032 | 1 | 0 | GAD |
| Angle Closure Glaucoma | 0.002367032 | 1 | 0 | GAD |
| Gout | 0.002367032 | 1 | 0 | GAD |
| Growth Disorders | 0.002367032 | 1 | 0 | GAD |
| Head and Neck Neoplasms | 0.002367032 | 1 | 0 | GAD |
| Hemiplegia | 0.002367032 | 1 | 0 | GAD |
| Herpesviridae Infections | 0.002367032 | 1 | 0 | GAD |
| Disorders of Excessive Somnolence | 0.002367032 | 1 | 0 | GAD |
| Neonatal disorder | 0.002367032 | 1 | 0 | GAD |
| Kidney Neoplasm | 0.002367032 | 1 | 0 | GAD |
| Lead Poisoning | 0.002367032 | 1 | 0 | GAD |
| Biliary cirrhosis | 0.002367032 | 1 | 0 | GAD |
| Lymphoma, Non-Hodgkin | 0.002367032 | 1 | 0 | GAD |
| Malaria, Falciparum | 0.002367032 | 1 | 0 | GAD |
| Animal Mammary Neoplasms | 0.002367032 | 1 | 0 | GAD |
| Mouth, Edentulous | 0.002367032 | 1 | 0 | GAD |
| Nasopharyngitis | 0.002367032 | 1 | 0 | GAD |
| Obesity, Morbid | 0.002367032 | 1 | 0 | GAD |
| Perceptual Disorders | 0.002367032 | 1 | 0 | GAD |
| Periodontal Diseases | 0.002367032 | 1 | 0 | GAD |
| Pregnancy Complications, Cardiovascular | 0.002367032 | 1 | 0 | GAD |
| Prenatal Exposure Delayed Effects | 0.002367032 | 1 | 0 | GAD |
| Rectal Neoplasms | 0.002367032 | 1 | 0 | GAD |
| Kaposi Sarcoma | 0.002367032 | 1 | 0 | GAD |
| Shock, Cardiogenic | 0.002367032 | 1 | 0 | GAD |
| Spinal Osteophytosis | 0.002367032 | 1 | 0 | GAD |
| Spondylosis | 0.002367032 | 1 | 0 | GAD |
| Substance Withdrawal Syndrome | 0.002367032 | 1 | 0 | GAD |
| Tinea Versicolor | 0.002367032 | 1 | 0 | GAD |
| Unconscious State | 0.002367032 | 1 | 0 | GAD |
| Uremia | 0.002367032 | 1 | 0 | GAD |
| Venous Thrombosis | 0.002367032 | 1 | 0 | GAD |
| Virilism | 0.002367032 | 1 | 0 | GAD |
| Low Vision | 0.002367032 | 1 | 0 | GAD |
| Vitamin B 12 Deficiency | 0.002367032 | 1 | 0 | GAD |
| Vitamin K Deficiency | 0.002367032 | 1 | 0 | GAD |
| Weight Gain | 0.002367032 | 1 | 0 | GAD |
| Holoprosencephaly | 0.002367032 | 1 | 0 | GAD |
| Lymphoma, AIDS-Related | 0.002367032 | 1 | 0 | GAD |
| Yin Deficiency | 0.002367032 | 1 | 0 | GAD |
| Epilepsy, Complex Partial | 0.002367032 | 1 | 0 | GAD |
| Left Ventricular Hypertrophy | 0.002367032 | 1 | 0 | GAD |
| Premature Birth | 0.002367032 | 1 | 0 | GAD |
| Intracranial Hypertension | 0.002367032 | 1 | 0 | GAD |
| Iron deficiency anemia | 0.002367032 | 1 | 0 | GAD |
| AIDS-Related Opportunistic Infections | 0.002367032 | 1 | 0 | GAD |
| Akathisia, Drug-Induced | 0.002367032 | 1 | 0 | GAD |
| Amyloid Neuropathies, Familial | 0.002367032 | 1 | 0 | GAD |
| Paramyxoviridae Infections | 0.002367032 | 1 | 0 | GAD |
| Personality Traits | 0.002367032 | 1 | 0 | GAD |
| Persistent Vegetative State | 0.002367032 | 1 | 0 | GAD |
| Sepsis | 0.002367032 | 1 | 0 | GAD |
| Vertebral Artery Dissection | 0.002367032 | 1 | 0 | GAD |
| Pancreatitis, Alcoholic | 0.002367032 | 1 | 0 | GAD |
| Traumatic cerebral hemorrhage | 0.002367032 | 1 | 0 | GAD |
| body mass | 0.002367032 | 1 | 0 | GAD |
| Paralysed | 0.002367032 | 1 | 0 | GAD |
| Mercury Poisoning, Nervous System | 0.002367032 | 1 | 0 | GAD |
| Menopause present (finding) | 0.002367032 | 1 | 0 | GAD |
| Hepatopulmonary Syndrome | 0.002367032 | 1 | 0 | GAD |
| Pregnancy loss | 0.002367032 | 1 | 0 | GAD |
| Chronic progressive chorea | 0.002367032 | 1 | 0 | GAD |
| Lead Poisoning, Nervous System, Adult | 0.002367032 | 1 | 0 | GAD |
| Lupus Vasculitis, Central Nervous System | 0.002367032 | 1 | 0 | GAD |
| Blood Coagulation Disorders, Inherited | 0.002367032 | 1 | 0 | GAD |
| Traumatic Brain Injury | 0.002367032 | 1 | 0 | GAD |
| Chlamydophila Infections | 0.002367032 | 1 | 0 | GAD |
| Microsatellite Instability | 0.002367032 | 1 | 0 | GAD |
| Cervical Dystonia | 0.002367032 | 1 | 0 | GAD |
| Blood pressure finding | 0.002367032 | 1 | 0 | GAD |
| Fetal Nutrition Disorders | 0.002367032 | 1 | 0 | GAD |
| Sjogren's Syndrome | 0.002367032 | 1 | 0 | GAD |
| Venous Thromboembolism | 0.002367032 | 1 | 0 | GAD |
| Memory Impairment Adverse Event | 0.002367032 | 1 | 0 | GAD |
| Weight Gain Adverse Event | 0.002367032 | 1 | 0 | GAD |
| Infection of amniotic sac and membranes, unspecified, unspecified trimester, not applicable or unspecified | 0.002367032 | 1 | 0 | GAD |
| Recurrent pregnancy loss | 0.002367032 | 1 | 0 | GAD |
| Essential Hypertension | 0.002171535 | 8 | 0 | BeFree |
| Cognitive deterioration | 0.002171535 | 8 | 0 | BeFree |
| Postoperative confusion | 0.002171535 | 8 | 0 | BeFree |
| Atherosclerosis of aorta | 0.001900093 | 7 | 0 | BeFree |
| Age-associated memory impairment | 0.001900093 | 7 | 0 | BeFree |
| Chronic Kidney Diseases | 0.001900093 | 7 | 16 | BeFree |
| Chronic kidney disease stage 5 | 0.001900093 | 7 | 0 | BeFree |
| Mixed dementia | 0.001900093 | 7 | 0 | BeFree |
| GRN-related frontotemporal dementia | 0.001900093 | 7 | 0 | BeFree |
| Anxiety Disorders | 0.001628651 | 6 | 0 | BeFree |
| Senile dementia | 0.001628651 | 6 | 0 | BeFree |
| Mental Retardation | 0.001628651 | 6 | 1 | BeFree |
| Aortic Aneurysm, Abdominal | 0.001628651 | 6 | 0 | BeFree |
| Age-related cognitive decline | 0.001628651 | 6 | 0 | BeFree |
| Overweight | 0.001628651 | 6 | 0 | BeFree |
| Intraocular pressure disorder | 0.001628651 | 6 | 0 | BeFree |
| Memory Loss | 0.001628651 | 6 | 0 | BeFree |
| Endothelial dysfunction | 0.001628651 | 6 | 0 | BeFree |
| Homocysteinemia | 0.001628651 | 6 | 1 | BeFree |
| Delusions | 0.001357209 | 5 | 0 | BeFree |
| Liver neoplasms | 0.001357209 | 5 | 0 | BeFree |
| Dissecting aneurysm of the thoracic aorta | 0.001357209 | 5 | 0 | BeFree |
| Alzheimer Disease, Early Onset | 0.001357209 | 5 | 0 | BeFree |
| Inclusion Body Myopathy, Sporadic | 0.001357209 | 5 | 0 | BeFree |
| Psychotic symptom | 0.001357209 | 5 | 0 | BeFree |
| Vascular inflammations | 0.001357209 | 5 | 0 | BeFree |
| Drusen | 0.001357209 | 5 | 0 | BeFree |
| Vascular lesions | 0.001357209 | 5 | 0 | BeFree |
| Amyotrophic Lateral Sclerosis, Sporadic | 0.001357209 | 5 | 0 | BeFree |
| Astrocytoma | 0.001085767 | 4 | 0 | BeFree |
| Colorectal Carcinoma | 0.001085767 | 4 | 0 | BeFree |
| Liver diseases | 0.001085767 | 4 | 0 | BeFree |
| Machado-Joseph Disease | 0.001085767 | 4 | 0 | BeFree |
| Stress, Psychological | 0.001085767 | 4 | 0 | BeFree |
| Virus Diseases | 0.001085767 | 4 | 0 | BeFree |
| Apathy | 0.001085767 | 4 | 0 | BeFree |
| Acute myocardial infarction | 0.001085767 | 4 | 1 | BeFree |
| Lesion of brain | 0.001085767 | 4 | 0 | BeFree |
| Exudative age-related macular degeneration | 0.001085767 | 4 | 0 | BeFree |
| Hyperuricemia | 0.001085767 | 4 | 0 | BeFree |
| Cerebral Ischemia | 0.001085767 | 4 | 0 | BeFree |
| Acute pancreatitis | 0.000814326 | 3 | 0 | BeFree |
| Cooley's anemia | 0.000814326 | 3 | 0 | BeFree |
| Bipolar Disorder | 0.000814326 | 3 | 0 | BeFree |
| Communication impairment | 0.000814326 | 3 | 1 | BeFree |
| Multi-infarct dementia | 0.000814326 | 3 | 0 | BeFree |
| Hodgkin Disease | 0.000814326 | 3 | 0 | BeFree |
| Hyperglycemia | 0.000814326 | 3 | 0 | BeFree |
| Hyperlipoproteinemia Type I | 0.000814326 | 3 | 0 | BeFree |
| Myoclonus | 0.000814326 | 3 | 0 | BeFree |
| Myotonic Dystrophy | 0.000814326 | 3 | 0 | BeFree |
| Sleep disturbances | 0.000814326 | 3 | 0 | BeFree |
| Deep Vein Thrombosis | 0.000814326 | 3 | 0 | BeFree |
| Psychiatric symptom | 0.000814326 | 3 | 0 | BeFree |
| Dementia associated with alcoholism | 0.000814326 | 3 | 0 | BeFree |
| Leukoencephalopathies | 0.000814326 | 3 | 0 | BeFree |
| Impaired glucose tolerance | 0.000814326 | 3 | 0 | BeFree |
| Xanthoma | 0.000814326 | 3 | 0 | BeFree |
| Infarction, Lacunar | 0.000814326 | 3 | 0 | BeFree |
| Arteriovenous hemangioma | 0.000814326 | 3 | 0 | BeFree |
| Endemic Cretinism | 0.000814326 | 3 | 0 | BeFree |
| Cholesteryl Ester Transfer Protein Deficiency | 0.000814326 | 3 | 0 | BeFree |
| Multiple System Atrophy | 0.000814326 | 3 | 0 | BeFree |
| Congenital Myotonic Dystrophy | 0.000814326 | 3 | 0 | BeFree |
| Prostate carcinoma | 0.000814326 | 3 | 0 | BeFree |
| Acute Cerebrovascular Accidents | 0.000814326 | 3 | 0 | BeFree |
| Hyperlipoproteinemia Type IIb | 0.000814326 | 3 | 0 | BeFree |
| NEUROTICISM | 0.000814326 | 3 | 0 | BeFree |
| INTELLIGENCE QUANTITATIVE TRAIT LOCUS 1 | 0.000814326 | 3 | 0 | BeFree |
| Combined hyperlipidemia | 0.000814326 | 3 | 0 | BeFree |
| Post-traumatic amnesia | 0.000542884 | 2 | 0 | BeFree |
| Brain Neoplasms | 0.000542884 | 2 | 0 | BeFree |
| Primary biliary cirrhosis | 0.000542884 | 2 | 0 | BeFree |
| Eclampsia | 0.000542884 | 2 | 0 | BeFree |
| Experimental Autoimmune Encephalomyelitis | 0.000542884 | 2 | 0 | BeFree |
| Exanthema | 0.000542884 | 2 | 0 | BeFree |
| IGA Glomerulonephritis | 0.000542884 | 2 | 0 | BeFree |
| Heart failure | 0.000542884 | 2 | 0 | BeFree |
| Congestive heart failure | 0.000542884 | 2 | 0 | BeFree |
| Hepatitis, Chronic | 0.000542884 | 2 | 0 | BeFree |
| Herpes NOS | 0.000542884 | 2 | 0 | BeFree |
| Keratitis, Herpetic | 0.000542884 | 2 | 0 | BeFree |
| Herpes zoster disease | 0.000542884 | 2 | 0 | BeFree |
| Hydrocephalus, Normal Pressure | 0.000542884 | 2 | 0 | BeFree |
| Lipodystrophy | 0.000542884 | 2 | 0 | BeFree |
| Macular degeneration | 0.000542884 | 2 | 0 | BeFree |
| Neoplasm Metastasis | 0.000542884 | 2 | 0 | BeFree |
| Neuroblastoma | 0.000542884 | 2 | 0 | BeFree |
| Ovarian Carcinoma | 0.000542884 | 2 | 0 | BeFree |
| Pituitary Diseases | 0.000542884 | 2 | 0 | BeFree |
| Retinal Diseases | 0.000542884 | 2 | 0 | BeFree |
| Shy-Drager Syndrome | 0.000542884 | 2 | 0 | BeFree |
| Tangier Disease | 0.000542884 | 2 | 0 | BeFree |
| Encephalopathies | 0.000542884 | 2 | 0 | BeFree |
| Synovial Cyst | 0.000542884 | 2 | 0 | BeFree |
| Cervical myelopathy | 0.000542884 | 2 | 0 | BeFree |
| Complex partial seizures | 0.000542884 | 2 | 0 | BeFree |
| Atrophic condition of skin | 0.000542884 | 2 | 0 | BeFree |
| Arterial thrombosis | 0.000542884 | 2 | 0 | BeFree |
| Adenocarcinoma of lung (disorder) | 0.000542884 | 2 | 0 | BeFree |
| Low Tension Glaucoma | 0.000542884 | 2 | 0 | BeFree |
| Eyelid Xanthoma | 0.000542884 | 2 | 0 | BeFree |
| Hearing Loss, Mixed Conductive-Sensorineural | 0.000542884 | 2 | 0 | BeFree |
| Old myocardial infarction | 0.000542884 | 2 | 0 | BeFree |
| Disease of capillaries | 0.000542884 | 2 | 0 | BeFree |
| Psychological symptom | 0.000542884 | 2 | 0 | BeFree |
| Hallucinations, Visual | 0.000542884 | 2 | 0 | BeFree |
| Prodrome | 0.000542884 | 2 | 0 | BeFree |
| Parkinsonian Disorders | 0.000542884 | 2 | 0 | BeFree |
| Cerebral Vasospasm | 0.000542884 | 2 | 0 | BeFree |
| Renal glomerular disease | 0.000542884 | 2 | 0 | BeFree |
| Stable angina | 0.000542884 | 2 | 0 | BeFree |
| Iodine deficiency syndrome | 0.000542884 | 2 | 0 | BeFree |
| Polygenic hypercholesterolemia | 0.000542884 | 2 | 0 | BeFree |
| dementia in parkinson's disease | 0.000542884 | 2 | 0 | BeFree |
| Corticobasal degeneration | 0.000542884 | 2 | 0 | BeFree |
| Neuropathy | 0.000542884 | 2 | 0 | BeFree |
| Endometrial Carcinoma | 0.000542884 | 2 | 0 | BeFree |
| Cerebrovascular amyloidosis | 0.000542884 | 2 | 0 | BeFree |
| Factor V Leiden mutation | 0.000542884 | 2 | 0 | BeFree |
| Progressive Neoplastic Disease | 0.000542884 | 2 | 0 | BeFree |
| Carcinoma of lung | 0.000542884 | 2 | 0 | BeFree |
| Secondary malignant neoplasm of lymph node | 0.000542884 | 2 | 0 | BeFree |
| Colon Carcinoma | 0.000542884 | 2 | 0 | BeFree |
| Central neuroblastoma | 0.000542884 | 2 | 0 | BeFree |
| Cardiovascular Pathology | 0.000542884 | 2 | 0 | BeFree |
| Hyperlipoproteinemia Type IIa | 0.000542884 | 2 | 0 | BeFree |
| Spots on skin | 0.000542884 | 2 | 0 | BeFree |
| Arteriopathic disease | 0.000542884 | 2 | 0 | BeFree |
| Cholesterol gallstones | 0.000542884 | 2 | 0 | BeFree |
| Macroangiopathy | 0.000542884 | 2 | 0 | BeFree |
| Malignant neoplasm of ovary | 0.000542884 | 2 | 0 | BeFree |
| Myxoid cyst | 0.000542884 | 2 | 0 | BeFree |
| Adenoma of large intestine | 0.000542884 | 2 | 0 | BeFree |
| Hippocampal sclerosis | 0.000542884 | 2 | 1 | BeFree |
| Mobility Limitation | 0.000542884 | 2 | 0 | BeFree |
| early onset schizophrenia | 0.000542884 | 2 | 0 | BeFree |
| Nephrotic Syndrome, Minimal Change | 0.000542884 | 2 | 0 | BeFree |
| CORONARY HEART DISEASE, SUSCEPTIBILITY TO, 5 | 0.000542884 | 2 | 0 | BeFree |
| Creutzfeldt-Jakob Disease, Sporadic | 0.000542884 | 2 | 0 | BeFree |
| Pediatric Obesity | 0.000542884 | 2 | 0 | BeFree |
| Acquired CJD | 0.000542884 | 2 | 0 | BeFree |
| Mild dementia | 0.000542884 | 2 | 0 | BeFree |
| Progressive cGVHD | 0.000542884 | 2 | 0 | BeFree |
| Abetalipoproteinemia | 0.000271442 | 1 | 0 | BeFree |
| Acromegaly | 0.000271442 | 1 | 0 | BeFree |
| Acute Disease | 0.000271442 | 1 | 0 | BeFree |
| Adrenal Cortex Diseases | 0.000271442 | 1 | 0 | BeFree |
| Retrograde amnesia | 0.000271442 | 1 | 0 | BeFree |
| Angina Pectoris, Variant | 0.000271442 | 1 | 0 | BeFree |
| Anomia | 0.000271442 | 1 | 0 | BeFree |
| Aortic Rupture | 0.000271442 | 1 | 0 | BeFree |
| Apraxias | 0.000271442 | 1 | 0 | BeFree |
| Asthma | 0.000271442 | 1 | 0 | BeFree |
| Tooth Attrition | 0.000271442 | 1 | 0 | BeFree |
| Bacterial Infections | 0.000271442 | 1 | 0 | BeFree |
| Blood Coagulation Disorders | 0.000271442 | 1 | 0 | BeFree |
| Malignant tumor of colon | 0.000271442 | 1 | 0 | BeFree |
| Rectal Carcinoma | 0.000271442 | 1 | 0 | BeFree |
| Squamous cell carcinoma | 0.000271442 | 1 | 0 | BeFree |
| Cholera | 0.000271442 | 1 | 0 | BeFree |
| Corneal Diseases | 0.000271442 | 1 | 0 | BeFree |
| Crohn Disease | 0.000271442 | 1 | 0 | BeFree |
| Deglutition Disorders | 0.000271442 | 1 | 0 | BeFree |
| Endometrial Hyperplasia | 0.000271442 | 1 | 0 | BeFree |
| Endometriosis | 0.000271442 | 1 | 0 | BeFree |
| Nodular glomerulosclerosis | 0.000271442 | 1 | 0 | BeFree |
| Headache | 0.000271442 | 1 | 0 | BeFree |
| Ventricular Septal Defects | 0.000271442 | 1 | 0 | BeFree |
| Heart valve disease | 0.000271442 | 1 | 0 | BeFree |
| Illusions | 0.000271442 | 1 | 0 | BeFree |
| Lecithin Acyltransferase Deficiency | 0.000271442 | 1 | 0 | BeFree |
| Left-Sided Heart Failure | 0.000271442 | 1 | 0 | BeFree |
| Malignant neoplasm of stomach | 0.000271442 | 1 | 0 | BeFree |
| melanoma | 0.000271442 | 1 | 0 | BeFree |
| Spinal Muscular Atrophy | 0.000271442 | 1 | 0 | BeFree |
| Mydriasis | 0.000271442 | 1 | 0 | BeFree |
| Myopia | 0.000271442 | 1 | 1 | BeFree |
| Myositis | 0.000271442 | 1 | 0 | BeFree |
| Neuromuscular Diseases | 0.000271442 | 1 | 0 | BeFree |
| Niemann-Pick Diseases | 0.000271442 | 1 | 0 | BeFree |
| Disorder of the optic nerve | 0.000271442 | 1 | 0 | BeFree |
| Optic Neuritis | 0.000271442 | 1 | 0 | BeFree |
| Degenerative polyarthritis | 0.000271442 | 1 | 0 | BeFree |
| Papilloma | 0.000271442 | 1 | 0 | BeFree |
| Postherpetic neuralgia | 0.000271442 | 1 | 0 | BeFree |
| Pseudoxanthoma Elasticum | 0.000271442 | 1 | 0 | BeFree |
| Quadriplegia | 0.000271442 | 1 | 0 | BeFree |
| Retinal Degeneration | 0.000271442 | 1 | 0 | BeFree |
| Schizophreniform Disorders | 0.000271442 | 1 | 0 | BeFree |
| Systemic Scleroderma | 0.000271442 | 1 | 0 | BeFree |
| Age-related cataract | 0.000271442 | 1 | 0 | BeFree |
| Shared Paranoid Disorder | 0.000271442 | 1 | 0 | BeFree |
| Sickle Cell Trait | 0.000271442 | 1 | 0 | BeFree |
| Siderosis | 0.000271442 | 1 | 0 | BeFree |
| Tic disorder | 0.000271442 | 1 | 0 | BeFree |
| Tremor | 0.000271442 | 1 | 0 | BeFree |
| Unspecified idiopathic peripheral neuropathy | 0.000271442 | 1 | 0 | BeFree |
| Cerebral Thrombosis | 0.000271442 | 1 | 0 | BeFree |
| B-Cell Lymphomas | 0.000271442 | 1 | 0 | BeFree |
| Pleural Effusion, Malignant | 0.000271442 | 1 | 0 | BeFree |
| Alagille Syndrome | 0.000271442 | 1 | 0 | BeFree |
| Hepatitis E | 0.000271442 | 1 | 0 | BeFree |
| Autosomal Recessive Polycystic Kidney Disease | 0.000271442 | 1 | 0 | BeFree |
| soft neurological signs | 0.000271442 | 1 | 0 | BeFree |
| Depressive Syndrome | 0.000271442 | 1 | 0 | BeFree |
| Intravenous Drug Abuse | 0.000271442 | 1 | 0 | BeFree |
| Pancreatitis, Chronic | 0.000271442 | 1 | 0 | BeFree |
| Genital ulceration | 0.000271442 | 1 | 0 | BeFree |
| Sensory neuropathy | 0.000271442 | 1 | 0 | BeFree |
| Patau syndrome | 0.000271442 | 1 | 0 | BeFree |
| Hypoplastic Left Heart Syndrome | 0.000271442 | 1 | 0 | BeFree |
| Lingual-Facial-Buccal Dyskinesia | 0.000271442 | 1 | 0 | BeFree |
| Common ventricle | 0.000271442 | 1 | 0 | BeFree |
| Malignant neoplasm of gallbladder | 0.000271442 | 1 | 0 | BeFree |
| Migraine with Aura | 0.000271442 | 1 | 0 | BeFree |
| Hepatoblastoma | 0.000271442 | 1 | 0 | BeFree |
| Teratocarcinoma | 0.000271442 | 1 | 0 | BeFree |
| Niemann-Pick Disease, Type C | 0.000271442 | 1 | 0 | BeFree |
| Systolic hypertension | 0.000271442 | 1 | 0 | BeFree |
| Premature aging syndrome | 0.000271442 | 1 | 0 | BeFree |
| Dysphoric mood | 0.000271442 | 1 | 0 | BeFree |
| Bradykinesia | 0.000271442 | 1 | 0 | BeFree |
| Amnesia, Anterograde | 0.000271442 | 1 | 0 | BeFree |
| Extrapyramidal sign | 0.000271442 | 1 | 0 | BeFree |
| Sensory denervation disorder | 0.000271442 | 1 | 0 | BeFree |
| Alcohol withdrawal syndrome | 0.000271442 | 1 | 0 | BeFree |
| Alcohol or Other Drugs use | 0.000271442 | 1 | 0 | BeFree |
| Anaplastic thyroid carcinoma | 0.000271442 | 1 | 0 | BeFree |
| Drug usage | 0.000271442 | 1 | 0 | BeFree |
| Parasitemia | 0.000271442 | 1 | 0 | BeFree |
| Carcinoma of ampulla of Vater | 0.000271442 | 1 | 0 | BeFree |
| Apraxia of Phonation | 0.000271442 | 1 | 0 | BeFree |
| Dilatation of aorta | 0.000271442 | 1 | 0 | BeFree |
| Chronic Periodontitis | 0.000271442 | 1 | 0 | BeFree |
| Oropharyngeal Dysphagia | 0.000271442 | 1 | 0 | BeFree |
| Progressive intrahepatic cholestasis (disorder) | 0.000271442 | 1 | 0 | BeFree |
| Amyloid nephropathy | 0.000271442 | 1 | 0 | BeFree |
| Localized amyloidosis | 0.000271442 | 1 | 0 | BeFree |
| Familial Cerebral Amyloid Angiopathy | 0.000271442 | 1 | 0 | BeFree |
| Hereditary Cerebral Amyloid Angiopathy, Dutch Type | 0.000271442 | 1 | 0 | BeFree |
| Amyloidosis, Primary Cutaneous | 0.000271442 | 1 | 0 | BeFree |
| Acute nephropathy | 0.000271442 | 1 | 0 | BeFree |
| Triplegia | 0.000271442 | 1 | 0 | BeFree |
| Cortical cataract | 0.000271442 | 1 | 0 | BeFree |
| Behavioral tic | 0.000271442 | 1 | 0 | BeFree |
| Iron Overload | 0.000271442 | 1 | 3 | BeFree |
| Sexual abuse | 0.000271442 | 1 | 0 | BeFree |
| Tuberous xanthoma | 0.000271442 | 1 | 0 | BeFree |
| Poisoning syndrome | 0.000271442 | 1 | 0 | BeFree |
| Segmental glomerulosclerosis | 0.000271442 | 1 | 0 | BeFree |
| Carotid artery dissection | 0.000271442 | 1 | 0 | BeFree |
| Silent myocardial ischemia | 0.000271442 | 1 | 0 | BeFree |
| Aortic aneurysm without mention of rupture NOS | 0.000271442 | 1 | 0 | BeFree |
| Dissection of aorta | 0.000271442 | 1 | 0 | BeFree |
| Chronic liver disease | 0.000271442 | 1 | 0 | BeFree |
| Tetralogy of Fallot with pulmonary atresia | 0.000271442 | 1 | 0 | BeFree |
| Wernicke-Korsakoff Syndrome | 0.000271442 | 1 | 0 | BeFree |
| Hereditary hemochromatosis | 0.000271442 | 1 | 3 | BeFree |
| Subcortical Vascular Dementia | 0.000271442 | 1 | 0 | BeFree |
| Thrombophilia | 0.000271442 | 1 | 0 | BeFree |
| Anxiety and fear | 0.000271442 | 1 | 0 | BeFree |
| Mobility poor | 0.000271442 | 1 | 0 | BeFree |
| Spastic | 0.000271442 | 1 | 0 | BeFree |
| Neurobehavioral Manifestations | 0.000271442 | 1 | 0 | BeFree |
| Hypersensitive syndrome | 0.000271442 | 1 | 0 | BeFree |
| Amyotrophic Lateral Sclerosis, Guam Form | 0.000271442 | 1 | 0 | BeFree |
| Post-Concussion Syndrome | 0.000271442 | 1 | 0 | BeFree |
| Chronic anxiety | 0.000271442 | 1 | 0 | BeFree |
| Severe depression | 0.000271442 | 1 | 0 | BeFree |
| cortex bone disorders | 0.000271442 | 1 | 0 | BeFree |
| Carcinogenesis | 0.000271442 | 1 | 0 | BeFree |
| Cardiovascular Infections | 0.000271442 | 1 | 0 | BeFree |
| Vascular rupture | 0.000271442 | 1 | 0 | BeFree |
| Tardive Dyskinesia | 0.000271442 | 1 | 0 | BeFree |
| heavy drinking | 0.000271442 | 1 | 0 | BeFree |
| Stomach Carcinoma | 0.000271442 | 1 | 0 | BeFree |
| Emotional distress | 0.000271442 | 1 | 0 | BeFree |
| Anxiety state | 0.000271442 | 1 | 0 | BeFree |
| Bile duct carcinoma | 0.000271442 | 1 | 0 | BeFree |
| Varicella zoster | 0.000271442 | 1 | 0 | BeFree |
| Intracranial Atherosclerosis | 0.000271442 | 1 | 0 | BeFree |
| Carotid Artery Plaque | 0.000271442 | 1 | 0 | BeFree |
| Primary Progressive Nonfluent Aphasia | 0.000271442 | 1 | 0 | BeFree |
| Dystonia, Primary | 0.000271442 | 1 | 0 | BeFree |
| Hypoxic-Ischemic Encephalopathy | 0.000271442 | 1 | 0 | BeFree |
| Thrombocytosis | 0.000271442 | 1 | 0 | BeFree |
| Fat redistribution | 0.000271442 | 1 | 0 | BeFree |
| Gallbladder sludge | 0.000271442 | 1 | 0 | BeFree |
| Loss of memory ability | 0.000271442 | 1 | 0 | BeFree |
| Arteriolosclerosis | 0.000271442 | 1 | 0 | BeFree |
| Transient Cerebral Ischemia | 0.000271442 | 1 | 0 | BeFree |
| Tauopathies | 0.000271442 | 1 | 0 | BeFree |
| Progressive multiple sclerosis | 0.000271442 | 1 | 0 | BeFree |
| Drug Resistant Epilepsy | 0.000271442 | 1 | 0 | BeFree |
| frontal dementia | 0.000271442 | 1 | 0 | BeFree |
| Recurrent genital herpes simplex | 0.000271442 | 1 | 0 | BeFree |
| Left ventricular systolic dysfunction | 0.000271442 | 1 | 0 | BeFree |
| Anxiety neurosis (finding) | 0.000271442 | 1 | 0 | BeFree |
| Lipoatrophy | 0.000271442 | 1 | 0 | BeFree |
| Degenerative disorder | 0.000271442 | 1 | 0 | BeFree |
| Peripheral arterial occlusive disease | 0.000271442 | 1 | 0 | BeFree |
| Arteriosclerosis of aorta | 0.000271442 | 1 | 0 | BeFree |
| Cirrhosis | 0.000271442 | 1 | 0 | BeFree |
| Peripheral Arterial Diseases | 0.000271442 | 1 | 0 | BeFree |
| Severe Sepsis | 0.000271442 | 1 | 0 | BeFree |
| Hard drusen | 0.000271442 | 1 | 0 | BeFree |
| Soft drusen | 0.000271442 | 1 | 0 | BeFree |
| INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE AND FRONTOTEMPORAL DEMENTIA | 0.000271442 | 1 | 0 | BeFree |
| SPEECH-SOUND DISORDER | 0.000271442 | 1 | 0 | BeFree |
| FRAGILE X TREMOR/ATAXIA SYNDROME | 0.000271442 | 1 | 0 | BeFree |
| MYELOPROLIFERATIVE DISORDER, CHRONIC, WITH EOSINOPHILIA | 0.000271442 | 1 | 0 | BeFree |
| Pyruvate Dehydrogenase E3-Binding Protein Deficiency | 0.000271442 | 1 | 0 | BeFree |
| Dementia, familial Danish | 0.000271442 | 1 | 0 | BeFree |
| Familial hypobetalipoproteinemia | 0.000271442 | 1 | 0 | BeFree |
| Daytime somnolence | 0.000271442 | 1 | 0 | BeFree |
| Iatrogenic Creutzfeldt-Jakob disease | 0.000271442 | 1 | 0 | BeFree |
| clinical depression | 0.000271442 | 1 | 0 | BeFree |
| Hypothalamic-pituitary-adrenal axis dysfunction | 0.000271442 | 1 | 0 | BeFree |
| Steatohepatitis | 0.000271442 | 1 | 0 | BeFree |
| Alcoholic Steatohepatitis | 0.000271442 | 1 | 0 | BeFree |
| Executive dysfunction | 0.000271442 | 1 | 0 | BeFree |
| Glycogen storage disease type Ia | 0.000271442 | 1 | 0 | BeFree |
| Visuospatial deficit | 0.000271442 | 1 | 0 | BeFree |
| Early-Stage Breast Carcinoma | 0.000271442 | 1 | 0 | BeFree |
| HYPERALPHALIPOPROTEINEMIA 1 | 0.000271442 | 1 | 0 | BeFree |
| PARKINSON DISEASE, LATE-ONSET | 0.000271442 | 1 | 0 | BeFree |
| Single Ventricle Defect | 0.000271442 | 1 | 0 | BeFree |
| Prodromal Period | 0.000271442 | 1 | 0 | BeFree |
| Severe dementia | 0.000271442 | 1 | 0 | BeFree |
| Dementia due to Alzheimer's disease (disorder) | 0.000271442 | 1 | 0 | BeFree |
| Dysexecutive syndrome | 0.000271442 | 1 | 0 | BeFree |
登陆
忘记密码? 点击找回密码.
